AKR1A1 and familial pancreatic carcinoma: In terms of protein molecular markers, the combination of macrophage inhibitory factor (MIC-1) and alcohol dehydrogenase (ADH) has been used in the diagnosis of early pancreatic cancer patients, with a specificity and sensitivity reaching 94 and 45.8%, respectively.